F255-0196 Screening compound: N-{4-[2-(1H-1,3-benzodiazol-2-yl)ethyl]phenyl}-8-methyl-2-phenylquinoline-4-carboxamide

F255-0196 Screening compound: N-{4-[2-(1H-1,3-benzodiazol-2-yl)ethyl]phenyl}-8-methyl-2-phenylquinoline-4-carboxamide
F255-0196 Screening compound: N-{4-[2-(1H-1,3-benzodiazol-2-yl)ethyl]phenyl}-8-methyl-2-phenylquinoline-4-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound F255-0196
N-{4-[2-(1H-1,3-benzodiazol-2-yl)ethyl]phenyl}-8-methyl-2-phenylquinoline-4-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F255-0196

Molecular Formula

C32H26N4O (C32 H26 N4 O)

Compound Name

N-{4-[2-(1H-1,3-benzodiazol-2-yl)ethyl]phenyl}-8-methyl-2-phenylquinoline-4-carboxamide

IUPAC name

N-{4-[2-(1H-13-benzodiazol-2-yl)ethyl]phenyl}-8-methyl-2-phenylquinoline-4-carboxamide

SMILES

Cc(cccc1c(C(Nc2ccc(CCc3nc(cccc4)c4[nH]3)cc2)=O)c2)c1nc2-c1ccccc1

InChI

InChI=1S/C32H26N4O/c1-21-8-7-11-25-26(20-29(36-31(21)25)23-9-3-2-4-10-23)32(37)33-24-17-14-22(15-18-24)16-19-30-34-27-12-5-6-13-28(27)35-30/h2-15,17-18,20H,16,19H2,1H3,(H,33,37)(H,34,35)

InChI Key

BFRKUTCTQUHQGX-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14946124

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

482.58

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

7.791

Distribution Coefficient, logD

7.766

Water Solubility, LogSw

-5.94

Polar Surface Area

52.169

Acid Dissociation Constant (pKa)

11.93

Base Dissociation Constant (pKb)

6.18

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

9.40

F255-0196 in Drug Discovery

Included in Screening Libraries

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Targets:
  • Phosphatases

References: we are preparing a list of scientific research reports with F255-0196 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F255-0196?
Check Price and Availability of F255-0196, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F255-0196 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F255-0196
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F255-0196
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F255-0196 available by request